Literature DB >> 15577683

Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer.

Gelareh Farshid1, Gill Rush.   

Abstract

Because some lesions diagnosed as radial scars (RS) on core biopsy have been found to be malignant on excision, core biopsy has not had an established role in the assessment of RS. In our breast cancer-screening program, we have avoided core biopsy if RS is suspected on imaging. Recently, two reports have expanded the experience with core biopsy of RS, prompting this review of our assessment protocols for lesions suspected as being RS. Between January 1996 and January 2003, stellate lesions with imaging features of RS in which core biopsy was omitted because of a presumptive radiologic diagnosis of RS are included. Demographic, radiologic, and cytologic data were correlated with the histologic findings in the excised specimen. On imaging, 9% (142) of all stellate lesions were suspected to be RS. Only 66.2% (94) were confirmed as RS on histology; 38 cases (28.6%) were carcinomas (36 invasive, 2 in situ) and 7% showed benign fibrocystic changes; 87.1% of the carcinomas required further surgery for positive margins. Axillary staging was also needed for the invasive cancers. Among the histologically proven RS, 28 of 94 (29.8%) showed areas of atypical ductal hyperplasia, lobular neoplasia, ductal carcinoma in situ, or invasive carcinoma. These proliferations were typically focal and unpredictable and were usually completely excised by the initial diagnostic biopsy. Core biopsy would be valuable in the assessment of lesions with imaging features suggestive of RS since 28.6% of such lesions are indeed carcinomas that mimic RS. Identification of these cancers would permit one stage breast and axillary surgery to be planned. The policy of mammographic surveillance for lesions with nonmalignant core biopsies remains controversial because of the paucity of data. Ongoing evaluation is needed as more experience is reported.

Entities:  

Mesh:

Year:  2004        PMID: 15577683     DOI: 10.1097/00000478-200412000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme.

Authors:  G Osborn; F Wilton; G Stevens; E Vaughan-Williams; K Gower-Thomas
Journal:  Ann R Coll Surg Engl       Date:  2010-11-12       Impact factor: 1.891

2.  Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy.

Authors:  Anthony G Douglas-Jones; Jemimah L Denson; Adam C Cox; Iwan B Harries; Guy Stevens
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

3.  Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary?

Authors:  Niamh Conlon; Clare D'Arcy; Jennifer B Kaplan; Zenica L Bowser; Anibal Cordero; Edi Brogi; Adriana D Corben
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

4.  Radial scar-significant diagnostic challenge.

Authors:  Zsófia Egyed; Zoltán Péntek; Balázs Járay; Janina Kulka; Egon Svastics; József Kas; Zsolt László
Journal:  Pathol Oncol Res       Date:  2008-04-12       Impact factor: 3.201

5.  Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Authors:  G Farshid; T Sullivan; P Downey; P G Gill; S Pieterse
Journal:  Br J Cancer       Date:  2011-11-03       Impact factor: 7.640

6.  Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data.

Authors:  G Farshid; P Downey; Pg Gill; S Pieterse
Journal:  Br J Cancer       Date:  2008-04-01       Impact factor: 7.640

7.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth Am O'Flynn; Christopher Comstock; Claudia Kurtz; Rahel Kubik; Helmut Madjar; Domenico Lepori; Gert Kampmann; Alexander Mundinger; Astrid Baege; Thomas Decker; Stefanie Hosch; Christoph Tausch; Jean-François Delaloye; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2016-08-13       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.